|
| |
21 USC Sec. 812 01/06/97
TITLE 21 - FOOD AND DRUGS
CHAPTER 13 - DRUG ABUSE PREVENTION AND CONTROL
SUBCHAPTER I - CONTROL AND ENFORCEMENT
Part B - Authority To Control; Standards and Schedules
Head
Sec. 812. Schedules of controlled substances
Statute
(a) Establishment
There are established five schedules of controlled substances, to
be known as schedules I, II, III, IV, and V. Such schedules shall
initially consist of the substances listed in this section. The
schedules established by this section shall be updated and
republished on a semiannual basis during the two-year period
beginning one year after October 27, 1970, and shall be updated and
republished on an annual basis thereafter.
(b) Placement on schedules; findings required
Except where control is required by United States obligations
under an international treaty, convention, or protocol, in effect
on October 27, 1970, and except in the case of an immediate
precursor, a drug or other substance may not be placed in any
schedule unless the findings required for such schedule are made
with respect to such drug or other substance. The findings
required for each of the schedules are as follows:
(1) Schedule I. -
(A) The drug or other substance has a high potential for abuse.
(B) The drug or other substance has no currently accepted
medical use in treatment in the United States.
(C) There is a lack of accepted safety for use of the drug or
other substance under medical supervision.
(2) Schedule II. -
(A) The drug or other substance has a high potential for abuse.
(B) The drug or other substance has a currently accepted
medical use in treatment in the United States or a currently
accepted medical use with severe restrictions.
(C) Abuse of the drug or other substances may lead to severe
psychological or physical dependence.
(3) Schedule III. -
(A) The drug or other substance has a potential for abuse less
than the drugs or other substances in schedules I and II.
(B) The drug or other substance has a currently accepted
medical use in treatment in the United States.
(C) Abuse of the drug or other substance may lead to moderate
or low physical dependence or high psychological dependence.
(4) Schedule IV. -
(A) The drug or other substance has a low potential for abuse
relative to the drugs or other substances in schedule III.
(B) The drug or other substance has a currently accepted
medical use in treatment in the United States.
(C) Abuse of the drug or other substance may lead to limited
physical dependence or psychological dependence relative to the
drugs or other substances in schedule III.
(5) Schedule V. -
(A) The drug or other substance has a low potential for abuse
relative to the drugs or other substances in schedule IV.
(B) The drug or other substance has a currently accepted
medical use in treatment in the United States.
(C) Abuse of the drug or other substance may lead to limited
physical dependence or psychological dependence relative to the
drugs or other substances in schedule IV.
(c) Initial schedules of controlled substances
Schedules I, II, III, IV, and V shall, unless and until amended
(FOOTNOTE 1) pursuant to section 811 of this title, consist of the
following drugs or other substances, by whatever official name,
common or usual name, chemical name, or brand name designated:
(FOOTNOTE 1) Revised schedules are published in the Code of
Federal Regulations, Part 1308 of Title 21, Food and Drugs.
SCHEDULE I
(a) Unless specifically excepted or unless listed in another
schedule, any of the following opiates, including their isomers,
esters, ethers, salts, and salts of isomers, esters, and ethers,
whenever the existence of such isomers, esters, ethers, and salts
is possible within the specific chemical designation:
(1) Acetylmethadol.
(2) Allylprodine.
(3) Alphacetylmathadol. (FOOTNOTE 2)
(FOOTNOTE 2) So in original. Probably should be
''Alphacetylmethadol.''
(4) Alphameprodine.
(5) Alphamethadol.
(6) Benzethidine.
(7) Betacetylmethadol.
(8) Betameprodine.
(9) Betamethadol.
(10) Betaprodine.
(11) Clonitazene.
(12) Dextromoramide.
(13) Dextrorphan.
(14) Diampromide.
(15) Diethylthiambutene.
(16) Dimenoxadol.
(17) Dimepheptanol.
(18) Dimethylthiambutene.
(19) Dioxaphetyl butyrate.
(20) Dipipanone.
(21) Ethylmethylthiambutene.
(22) Etonitazene.
(23) Etoxeridine.
(24) Furethidine.
(25) Hydroxypethidine.
(26) Ketobemidone.
(27) Levomoramide.
(28) Levophenacylmorphan.
(29) Morpheridine.
(30) Noracymethadol.
(31) Norlevorphanol.
(32) Normethadone.
(33) Norpipanone.
(34) Phenadoxone.
(35) Phenampromide.
(36) Phenomorphan.
(37) Phenoperidine.
(38) Piritramide.
(39) Propheptazine.
(40) Properidine.
(41) Racemoramide.
(42) Trimeperidine.
(b) Unless specifically excepted or unless listed in another
schedule, any of the following opium derivatives, their salts,
isomers, and salt of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific
chemical designation:
(1) Acetorphine.
(2) Acetyldihydrocodeine.
(3) Benzylmorphine.
(4) Codeine methylbromide.
(5) Codeine-N-Oxide.
(6) Cyprenorphine.
(7) Desomorphine.
(8) Dihydromorphine.
(9) Etorphine.
(10) Heroin.
(11) Hydromorphinol.
(12) Methyldesorphine.
(13) Methylhydromorphine.
(14) Morphine methylbromide.
(15) Morphine methylsulfonate.
(16) Morphine-N-Oxide.
(17) Myrophine.
(18) Nicocodeine.
(19) Nicomorphine.
(20) Normorphine.
(21) Pholcodine.
(22) Thebacon.
(c) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation, which
contains any quantity of the following hallucinogenic substances,
or which contains any of their salts, isomers, and salts of isomers
whenever the existence of such salts, isomers, and salts of isomers
is possible within the specific chemical designation:
(1) 3,4-methylenedioxy amphetamine.
(2) 5-methoxy-3,4-methylenedioxy amphetamine.
(3) 3,4,5-trimethoxy amphetamine.
(4) Bufotenine.
(5) Diethyltryptamine.
(6) Dimethyltryptamine.
(7) 4-methyl-2,5-diamethoxyamphetamine.
(8) Ibogaine.
(9) Lysergic acid diethylamide.
(10) Marihuana.
(11) Mescaline.
(12) Peyote.
(13) N-ethyl-3-piperidyl benzilate.
(14) N-methyl-3-piperidyl benzilate.
(15) Psilocybin.
(16) Psilocyn.
(17) Tetrahydrocannabinols.
SCHEDULE II
(a) Unless specifically excepted or unless listed in another
schedule, any of the following substances whether produced directly
or indirectly by extraction from substances of vegetable origin, or
independently by means of chemical synthesis, or by a combination
of extraction and chemical synthesis:
(1) Opium and opiate, and any salt, compound, derivative, or
preparation of opium or opiate.
(2) Any salt, compound, derivative, or preparation thereof
which is chemically equivalent or identical with any of the
substances referred to in clause (1), except that these
substances shall not include the isoquinoline alkaloids of opium.
(3) Opium poppy and poppy straw.
(4) coca (FOOTNOTE 3) leaves, except coca leaves and extracts
of coca leaves from which cocaine, ecgonine, and derivatives of
ecgonine or their salts have been removed; cocaine, its salts,
optical and geometric isomers, and salts of isomers; ecgonine,
its derivatives, their salts, isomers, and salts of isomers; or
any compound, mixture, or preparation which contains any quantity
of any of the substances referred to in this paragraph.
(FOOTNOTE 3) So in original. Probably should be capitalized.
(b) Unless specifically excepted or unless listed in another
schedule, any of the following opiates, including their isomers,
esters, ethers, salts, and salts of isomers, esters and ethers,
whenever the existence of such isomers, esters, ethers, and salts
is possible within the specific chemical designation:
(1) Alphaprodine.
(2) Anileridine.
(3) Bezitramide.
(4) Dihydrocodeine.
(5) Diphenoxylate.
(6) Fentanyl.
(7) Isomethadone.
(8) Levomethorphan.
(9) Levorphanol.
(10) Metazocine.
(11) Methadone.
(12) Methadone-Intermediate,
4-cyano-2-dimethylamino-4,4-diphenyl butane.
(13) Moramide-Intermediate, 2-methyl-3-morpholino-1,
1-diphenylpropane-carboxylic acid.
(14) Pethidine.
(15) Pethidine-Intermediate-A,
4-cyano-1-methyl-4-phenylpiperidine.
(16) Pethidine-Intermediate-B,
ethyl-4-phenylpiperidine-4-carboxylate.
(17) Pethidine-Intermediate-C,
1-methyl-4-phenylpiperidine-4-carboxylic acid.
(18) Phenazocine.
(19) Piminodine.
(20) Racemethorphan.
(21) Racemorphan.
(c) Unless specifically excepted or unless listed in another
schedule, any injectable liquid which contains any quantity of
methamphetamine, including its salts, isomers, and salts of
isomers.
SCHEDULE III
(a) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a
stimulant effect on the central nervous system:
(1) Amphetamine, its salts, optical isomers, and salts of its
optical isomers.
(2) Phenmetrazine and its salts.
(3) Any substance (except an injectable liquid) which contains
any quantity of methamphetamine, including its salts, isomers,
and salts of isomers.
(4) Methylphenidate.
(b) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a
depressant effect on the central nervous system:
(1) Any substance which contains any quantity of a derivative
of barbituric acid, or any salt of a derivative of barbituric
acid.
(2) Chorhexadol.
(3) Glutehimide.
(4) Lysergic acid.
(5) Lysergic acid amide.
(6) Methyprylon.
(7) Phencyclidine.
(8) Sulfondiethylmethane.
(9) Sulfonethylmethane.
(10) Sulfonmethane.
(c) Nalorphine.
(d) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation
containing limited quantities of any of the following narcotic
drugs, or any salts thereof:
(1) Not more than 1.8 grams of codeine per 100 milliliters or
not more than 90 milligrams per dosage unit, with an equal or
greater quantity of an isoquinoline alkaloid of opium.
(2) Not more than 1.8 grams of codeine per 100 milliliters or
not more than 90 milligrams per dosage unit, with one or more
active, non-narcotic ingredients in recognized therapeutic
amounts.
(3) Not more than 300 milligrams of dihydrocodeinone per 100
milliliters or not more than 15 milligrams per dosage unit, with
a fourfold or greater quantity of an isoquinoline alkaloid of
opium.
(4) Not more than 300 milligrams of dihydrocodeinone per 100
milliliters or not more than 15 milligrams per dosage unit, with
one or more active, nonnarcotic ingredients in recognized
therapeutic amounts.
(5) Not more than 1.8 grams of dihydrocodeine per 100
milliliters or not more than 90 milligrams per dosage unit, with
one or more active, nonnarcotic ingredients in recognized
therapeutic amounts.
(6) Not more than 300 milligrams of ethylmorphine per 100
milliliters or not more than 15 milligrams per dosage unit, with
one or more active, nonnarcotic ingredients in recognized
therapeutic amounts.
(7) Not more than 500 milligrams of opium per 100 milliliters
or per 100 grams, or not more than 25 milligrams per dosage unit,
with one or more active, nonnarcotic ingredients in recognized
therapeutic amounts.
(8) Not more than 50 milligrams of morphine per 100 milliliters
or per 100 grams with one or more active, nonnarcotic ingredients
in recognized therapeutic amounts.
(e) Anabolic steroids.
SCHEDULE IV
(1) Barbital.
(2) Chloral betaine.
(3) Chloral hydrate.
(4) Ethchlorvynol.
(5) Ethinamate.
(6) Methohexital.
(7) Meprobamate.
(8) Methylphenobarbital.
(9) Paraldehyde.
(10) Petrichloral.
(11) Phenobarbital.
SCHEDULE V
Any compound, mixture, or preparation containing any of the
following limited quantities of narcotic drugs, which shall include
one or more nonnarcotic active medicinal ingredients in sufficient
proportion to confer upon the compound, mixture, or preparation
valuable medicinal qualities other than those possessed by the
narcotic drug alone:
(1) Not more than 200 milligrams of codeine per 100 milliliters
or per 100 grams.
(2) Not more than 100 milligrams of dihydrocodeine per 100
milliliters or per 100 grams.
(3) Not more than 100 milligrams of ethylmorphine per 100
milliliters or per 100 grams.
(4) Not more than 2.5 milligrams of diphenoxylate and not less
than 25 micrograms of atropine sulfate per dosage unit.
(5) Not more than 100 milligrams of opium per 100 milliliters
or per 100 grams.
Source
(Pub. L. 91-513, title II, Sec. 202, Oct. 27, 1970, 84 Stat. 1247;
Pub. L. 95-633, title I, Sec. 103, Nov. 10, 1978, 92 Stat. 3772;
Pub. L. 98-473, title II, Sec. 507(c), 509(b), Oct. 12, 1984, 98
Stat. 2071, 2072; Pub. L. 99-570, title I, Sec. 1867, Oct. 27,
1986, 100 Stat. 3207-55; Pub. L. 99-646, Sec. 84, Nov. 10, 1986,
100 Stat. 3619; Pub. L. 101-647, title XIX, Sec. 1902(a), Nov. 29,
1990, 104 Stat. 4851.)
Misc1
AMENDMENTS
1990 - Subsec. (c). Pub. L. 101-647 added item (e) at end of
schedule III.
1986 - Subsec. (c). Pub. L. 99-646 amended schedule II(a)(4)
generally. Prior to amendment, schedule II(a)(4) read as follows:
''Coca leaves (except coca leaves and extracts of coca leaves from
which cocaine, ecgonine, and derivatives of ecgonine or their salts
have been removed); cocaine, its salts, optical and geometric
isomers, and salts of isomers; and ecgonine, its derivatives, their
salts, isomers, and salts of isomers.''
Pub. L. 99-570 amended schedule II(a)(4) generally. Prior to
amendment, schedule II(a)(4) read as follows: ''Coca leaves and any
salt, compound, derivative, or preparation of coca leaves
(including cocaine and ecgonine and their salts, isomers,
derivatives, and salts of isomers and derivatives), and any salt,
compound, derivative, or preparation thereof which is chemically
equivalent or identical with any of these substances, except that
the substances shall not include decocainized coca leaves or
extraction of coca leaves, which extractions do not contain cocaine
or ecgonine.''
1984 - Subsec. (c). Pub. L. 98-473, Sec. 507(c), in schedule
II(a)(4) added applicability to cocaine and ecgonine and their
salts, isomers, etc.
Subsec. (d). Pub. L. 98-473, Sec. 509(b), struck out subsec. (d)
which related to authority of Attorney General to except stimulants
or depressants containing active medicinal ingredients.
1978 - Subsec. (d)(3). Pub. L. 95-633 added cl. (3).
EFFECTIVE DATE OF 1990 AMENDMENT
Amendment by Pub. L. 101-647 effective 90 days after Nov. 29,
1990, see section 1902(d) of Pub. L. 101-647, set out as a note
under section 802 of this title.
EFFECTIVE DATE OF 1978 AMENDMENT
Amendment by Pub. L. 95-633 effective on date the Convention on
Psychotropic Substances enters into force in the United States
(July 15, 1980), see section 112 of Pub. L. 95-633, set out as an
Effective Date note under section 801a of this title.
PLACEMENT OF PIPRADROL AND SPA IN SCHEDULE IV TO CARRY OUT
OBLIGATION UNDER CONVENTION ON PSYCHOTROPIC SUBSTANCES
Section 102(c) of Pub. L. 95-633 provided that: ''For the purpose
of carrying out the minimum United States obligations under
paragraph 7 of article 2 of the Convention on Psychotropic
Substances, signed at Vienna, Austria, on February 21, 1971, with
respect to pipradrol and SPA (also known as
(-)-1-dimethylamino-1,2-diphenylethane), the Attorney General shall
by order, made without regard to sections 201 and 202 of the
Controlled Substances Act (this section and section 811 of this
title), place such drugs in schedule IV of such Act (see subsec.
(c) of this section).''
Provision of section 102(c) of Pub. L. 95-633, set out above,
effective on the date the Convention on Psychotropic Substances
enters into force in the United States (July 15, 1980), see section
112 of Pub. L. 95-633, set out as an Effective Date note under
section 801a of this title.
Sec Ref
SECTION REFERRED TO IN OTHER SECTIONS
This section is referred to in sections 811, 1115 of this title;
title 10 section 912a; title 19 section 2484; title 29 sections
706, 2006; title 41 section 706; title 42 sections 12111, 12210.
|
